Dow Up 1.33% Nasdaq Up 1.33%

Intra-Cellular Therapies, Inc. (ITCI)

-NasdaqGS
38.82 Up 1.39(3.71%) 4:00PM EDT
Prev Close:37.43
Open:37.48
Bid:38.80 x 200
Ask:38.83 x 200
1y Target Est:74.25
Beta:N/A
Earnings Date:Aug 3 - Aug 8 (Est.)
Day's Range:37.02 - 38.90
52wk Range:21.19 - 60.79
Volume:626,937
Avg Vol (3m):458,867
Market Cap:1.68B
P/E (ttm):N/A
EPS (ttm):-2.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ITCI

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18,378.11
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-3.14
Quarterly EPS Est (Jun-16) :-0.79
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Intra-Cellular Therapies, Inc., a biopharmaceutical company, discovers and develops small molecule drugs for the treatment of neuropsychiatric and neurologic disorders within the central nervous system (CNS). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback